ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
KR
Kazakh Research Institute of Oncology and Radiology at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Kazakh Research Institute of Oncology and Radiology takes part in 3 sessions at ESMO 2026 in Madrid. Its work focuses on breast cancer treatment access and inherited risk. It examines real-world olaparib treatment in BRCA-mutated breast cancer and germline mutations that could inform screening in Kazakh women.
| Organization | ESMO 2026 Attendance |
|---|---|
KR Kazakh Research Institute of Oncology and Radiology Almaty, Kazakhstan | |
Oncology and radiology research and treatment institute in Almaty, Kazakhstan. | Poster Fri Oct 23 13:00–15:00 A government-mandated public-philanthropic partnership as a catalyst for sustainable drug access: Real-world evidence from 1,112 patients across 18 regions of Kazakhstan Gastrointestinal cancersLung & thoracic cancersBreast cancer Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Spectrum of germline mutations associated with breast cancer in Kazakh women: Implications for population-specific genetic screening Breast cancerBiomarkers & precision oncology |
Find decision makers at Kazakh Research Institute of Oncology and Radiology
Tell us what you sell and we’ll find the people at Kazakh Research Institute of Oncology and Radiology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction